Favipiravir is an important selective
antiviral against
RNA-based
viruses, and currently, it is being repurposed as a potential drug
for the treatment of COVID-19. This type of chemical system presents
different carboxamide-rotameric and hydroxyl-tautomeric states, which
could be essential for interpreting its selective antiviral activity.
Herein, the tautomeric 3-hydroxypyrazine/3-pyrazinone pair of favipiravir
and its 6-substituted analogues, 6-Cl, 6-Br, 6-I, and 6-H, were fully
investigated in solution and in the solid state through ultraviolet–visible, 1H nuclear magnetic resonance, infrared spectroscopy, and X-ray
diffraction techniques. Also, a study of the gas phase was performed
using density functional theory calculations. In general, the keto–enol
balance in these 3-hydroxy-2-pyrazinecarboxamides is finely modulated
by external and internal electrical variations via changes in solvent
polarity or by replacement of substituents at position 6. The enol
tautomer was prevalent in an apolar environment, whereas an increase
in the level of the keto tautomer was favored by an increase in solvent
polarity and, even moreso, with a strong hydrogen-donor solvent. Keto
tautomerization was favored either in solution or in the solid state
with a decrease in 6-substituent electronegativity as follows: H ≫
I ≈ Br > Cl ≥ F. Specific rotameric states based
on
carboxamide, “cisoide” and “transoide”,
were identified for the enol and keto tautomer, respectively; their
rotamerism is dependent on the tautomerism and not the aggregation
state.